News for Healthier Living

Study Reveals Synergistic Effect of CDK2 and CDK4/6 Combination Therapy

A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Communications, identifies a powerful strategy to overcome drug resistance in breast cancer by simultaneously targeting two key cell-cycle regulators, CDK2 and CDK4/6.

January 22, 2026


January 22 2026

January 21 2026

January 20 2026

January 19 2026

January 18 2026

January 17 2026

January 16 2026

January 15 2026

January 14 2026

January 13 2026

January 12 2026

January 11 2026

January 10 2026

January 9 2026

January 8 2026